Sarah holds a Masters Degree in Physiology and Phd in Epidemiology from the University of Toronto. Sarah presently holds the position of the Global Director, Risk Management Alliance & Strategy at AstraZeneca. She previously held the role of Director, Patient Safety and Medical Information at AstraZeneca Canada. Sarah holds a faculty position in Epidemiology at the University of Toronto and is an active member of many Pharmacovigilance working groups including ISPE BRACE subject interest group and IsOP Asia Risk Minimisation subject interest group. She has a special interest in related to effectiveness of Risk Mitigation Interventions.